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Abstract
 
Genetic studies have revealed that Cbl-b plays a negative role in the antigen receptor–mediated
proliferation of lymphocytes. However, we show that Cbl-b–deficient DT40 B cells display re-
duced phospholipase C (PLC)-
 
 
 
2 activation and Ca
 
2
 
 
 
 mobilization upon B cell receptor
(BCR) stimulation. In addition, the overexpression of Cbl-b in WEHI-231 mouse B cells re-
 
sulted in the augmentation of BCR-induced Ca
 
2
 
 
 
 mobilization. Cbl-b interacted with PLC-
 
 
 
2
and helped the association of PLC-
 
 
 
2 with Bruton’s tyrosine kinase (Btk), as well as B cell
linker protein (BLNK). Cbl-b was indispensable for Btk-dependent sustained increase in intra-
cellular Ca
 
2
 
 
 
. Both NH
 
2
 
-terminal tyrosine kinase-binding domain and COOH-terminal half
region of Cbl-b were essential for its association with PLC-
 
 
 
2 and the regulation of Ca
 
2
 
 
 
 mo-
bilization. These results demonstrate that Cbl-b positively regulates BCR-mediated Ca
 
2
 
 
 
 sig-
naling, most likely by influencing the Btk/BLNK/PLC-
 
 
 
2 complex formation.
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Introduction
 
The B cell receptor (BCR)
 
*
 
 complex, consisting of mem-
brane-bound immunoglobulin and Ig-
 
 
 
/
 
 
 
 heterodimer,
transmits signals that regulate the survival, differentiation,
and proliferation of B lymphocytes (1–3). The Ig-
 
 
 
/
 
 
 
 het-
erodimer, an integral component of the surface expression
and signaling function of BCR, contains immunoreceptor
tyrosine-based activation motif (ITAM), a common motif
also found in the receptor complexes of other cells in the
immune system including T, NK, and mast cells (4, 5). En-
gagement of the BCR initiates signaling cascades beginning
with the activation of cytoplasmic protein tyrosine kinases
(PTKs) and the phosphorylation of ITAM. Three distinct
families of nonreceptor PTKs, Src family PTKs, Syk, and
Bruton’s tyrosine kinase (Btk), are activated upon BCR
engagement and contribute to the activation of multiple
downstream effectors such as Ras–mitogen-activated pro-
tein kinase (MAPK), phosphatidylinositol 3-kinase (PI3K),
and phospholipase C (PLC)-
 
 
 
2 (3, 6–8). PLC-
 
 
 
2 converts
phosphatidylinositol 4,5-bisphosphate into the two second
messengers, diacylglycerol and inositol 1,4,5-trisphosphate
 
(IP
 
3
 
), which leads to the activation of protein kinase C
and Ca
 
2
 
 
 
 mobilization, respectively. PLC-
 
 
 
2 is activated
through its tyrosine phosphorylation by Syk and Btk after
BCR stimulation (9–11). Recent studies have demon-
strated that BCR-mediated PLC-
 
 
 
2 activation also requires
association with B cell linker protein (BLNK), which is re-
sponsible for PLC-
 
 
 
2 membrane translocation (12).
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3
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Positive Role for Cbl-b in BCR Signaling
 
The mammalian Cbl family is made up of Cbl, Cbl-b,
and Cbl-c/Cbl-3. They all have a tyrosine kinase–binding
(TKB) domain, a RING finger domain, and a proline-rich
region (13–15). The TKB domain, also called the Cbl-N
domain, is an integrated phosphopeptide-binding platform
composed of a four-helical bundle, a Ca
 
2
 
 
 
-binding EF
hand, and an SH2 domain (16). The Cbl family proteins
are tyrosine phosphorylated upon the stimulation of epi-
dermal growth factor receptor (EGFR), platelet-derived
growth factor receptor, as well as ITAM-related receptors,
such as TCR, BCR, and Fc receptors. The importance of
Cbl family proteins in intracellular signal transduction is ad-
ditionally emphasized by the observation that Cbl and Cbl-b
interact with critical signaling molecules, such as Src family
PTKs, Zap-70/Syk family PTKs, p85 subunit of PI3K,
Vav, and Slp-76/BLNK family linker proteins (13, 17–19).
Recent studies have also shown that Cbl family proteins re-
cruit ubiquitin-conjugating enzymes (E2) via the RING
finger domain, allowing ubiquitination and degradation of
phosphorylated substrates (20).
Cbl and Cbl-b are abundantly expressed in a variety of
immune cells. Although they share an evolutionary con-
served NH
 
2
 
-terminal region, Cbl and Cbl-b play distinct
roles in the activation and development of lymphocytes.
Thymocytes of Cbl-deficient mice exhibit enhanced posi-
tive selection of CD4
 
  
 
cells, increased surface expression of
TCR/CD3 and CD4, and hyperphosphorylation of Zap-
70 after CD3 stimulation (21, 22). In contrast, Cbl-b–defi-
cient mice show normal thymic development, but mature
T and B cells of Cbl-b–deficient mice are hyperprolifera-
tive. These mice develop spontaneous autoimmunity, and
Cbl-b deficiency uncouples T cell proliferation, IL-2 pro-
duction, and phosphorylation of Vav from the requirement
for CD28 costimulation (17, 23). In addition, recent studies
show that Cbl-b not only regulates Vav, but also other sig-
naling molecules such as PI3K downstream of TCR (24).
To further dissect the roles of Cbl-b in BCR signaling, we
established Cbl-b–deficient DT40 B cell lines by the gene
targeting method. In contrast to Cbl-deficient DT40 cells,
Cbl-b–deficient DT40 cells exhibited attenuated activation
of PLC-
 
 
 
2, Ca
 
2
 
 
 
 mobilization, and c-Jun NH
 
2
 
-terminal
kinase (JNK) in response to BCR stimulation. Our data
suggest that Cbl-b is important for Btk/BLNK/PLC-
 
 
 
2
complex formation, which is required for downstream
Ca
 
2
 
 
 
 mobilization.
 
Materials and Methods
 
Cells and Abs.
 
DT40 cells were maintained in RPMI 1640
medium supplemented with 10% fetal bovine serum, 1% chicken
serum, and 50 
 
 
 
M 
 
 
 
-mercaptoethanol. Lyn-, Syk-, Btk-, and
Cbl-deficient DT40 cells have been described previously (10, 11,
18). WEHI-231 cells were cultured in RPMI 1640 medium sup-
plemented with 10% fetal bovine serum and 50 
 
 
 
M 
 
 
 
-mercapto-
ethanol. B cells from the spleens of 8–13-wk-old mice were en-
riched by negative selection with mAbs against CD3
 
 
 
, CD11b,
and NK1.1. The resulting cells were 
 
 
 
85% B220
 
 
 
, as assessed by
flow cytometry. The Abs for chicken PLC-
 
 
 
2, chicken Syk,
chicken BLNK, and chicken Lyn were described previously (10,
25). Mouse monoclonal IgM toward chicken 
 
 
 
 chains (M4) was
used for IgM cross-linking on DT40 cells (26). The following
Abs were purchased: anti–Cbl-b (C-20), anti–Cbl-b (G-1), anti–
mouse PLC-
 
 
 
2, anti-Rap1, anti–extracellular signal-regulated ki-
nase (ERK)2, and anti-p38 (Santa Cruz Biotechnology, Inc.);
anti-JNK1 (BD PharMingen), anti-T7 epitope (Novagen), anti-
phosphotyrosine (4G10; Upstate Biotechnology), anti–
 
 
 
-tubulin
(Oncogene Research Products); and anti–mouse IgM (
 
 
 
 chain
specific; Sigma-Aldrich). The Abs against Cbl-b used in this study
specifically recognized Cbl-b but not Cbl. Anti-T7 mAb did not
react to chicken Cbl-b, BLNK, and PLC-
 
 
 
2. Flow cytometric
analysis was performed as described previously (18).
 
Generation of Cbl-b–deficient DT40 Cells. 
 
A partial chicken
Cbl-b cDNA was cloned by reverse transcription–PCR with
RNA from DT40 cells and degenerate primers in the conserved
region between Cbl and Cbl-b (amino acids 67–418 in human
Cbl-b). On the basis of the chicken Cbl-b cDNA sequence,
chicken genomic fragments were obtained by PCR with chicken
genomic DNA as a template. The targeting vectors, pCbl-b-neo
and pCbl-b-hisD, were constructed by replacing the genomic
fragment–containing exon corresponding to human Cbl-b amino
acids 242–281 with 
 
neo
 
 and 
 
hisD
 
 cassettes, respectively. These
cassettes were flanked by 3.5- and 3.0-kb chicken Cbl-b genomic
sequences on the 5
 
  
 
and 3
 
  
 
side, respectively. The targeting vector
pCbl-b-neo was linearized and introduced into wild-type DT40
cells by electroporation at 550 V and 25 
 
 
 
F. Selection was done
in the presence of 2 mg/ml G418, and G418-resistant clones
were screened by Southern blot analysis for the targeted allele.
pCbl-b-hisD was transfected into the neo-targeted clone and se-
lected with both 1 mg/ml G418 and 1 mg/ml histidinol. Intro-
duction of a single copy of each targeting vector was verified by
reprobing the blots with internal 
 
neo
 
 or 
 
hisD
 
 probe.
 
Expression Constructs. 
 
Alternatively spliced form of human
Cbl-b cDNA, which lacks 767–810 amino acids (provided by S.
Lipkowitz, Bethesda Naval Hospital, Bethesda, MD; reference
27), was subcloned into the pApuro expression vector (10). Mu-
tation of Gly-298 to Glu, designated GE, and Cys-373 to Ala,
designated CA, were introduced into the human Cbl-b cDNA by
PCR-directed mutagenesis, respectively. The human Cbl-b se-
quence encoding amino acids 1–444, designated N, was gener-
ated by SphI site–mediated deletion. GE, N, and CA were sub-
cloned into the pApuro expression vector. Transfection into B
cells was performed by electroporation at 550 V and 25 
 
 
 
F. Se-
lection was performed in the presence of 0.5 
 
 
 
g/ml puromycin.
T7-tagged Btk cDNA (28) subcloned into the pAhygro expres-
sion vector was transfected into wild-type or Cbl-b–deficient
(C3-3) DT40 cells. The pAhygro vector was generated by replac-
ing a puromycin-resistant gene of the pApuro vector by a hygro-
mycin-resistant gene. Selection was performed in the presence of
2 mg/ml hygromycin B. Expression of Cbl-b or T7-Btk in each
transfectant was confirmed by Western blot analysis.
 
Northern Blot Analysis.
 
RNA was prepared using the guani-
dium thiocyanate method. Total RNA (20 
 
 
 
g) was separated on
a 1.2% formaldehyde gel, transferred to Hybond N
 
  
 
nylon mem-
brane (Amersham Pharmacia Biotech), and probed with 
 
32
 
P-
labeled chicken 
 
cbl-b
 
 and chicken 
 
actin
 
 cDNAs.
 
Immunoprecipitation and Western Blot Analysis. 
 
Cells were sol-
ubilized in 1% NP-40 lysis buffer (1% NP-40, 150 mM NaCl, 20
mM Tris, pH 7.5, and 1 mM EDTA) containing protease and
phosphatase inhibitors as described previously (10), or in 0.2%
NP-40 lysis buffer (0.2% NP-40, 10 mM Hepes, pH 7.0, 143
mM KCl, 5 mM MgCl
 
2
 
, 1 mM phenylmethylsulfonyl fluoride, 
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10 
 
 
 
g/ml leupeptin, 10 
 
 
 
g/ml aprotinin, and 1 mM sodium
orthovanadate). Precleared lysates were sequentially incubated
with appropriate Abs and protein A/G–Sepharose beads. The im-
munoprecipitates were washed four times with lysis buffer.
Whole cell lysates or immunoprecipitates were separated by SDS-
PAGE, transferred to polyvinylidene difluoride membrane, and
detected by appropriate Abs and chemiluminescence (NEN Life
Science Products).
 
Preparation of Glycolipid-enriched Microdomain (GEM) Fractions.
 
5 
 
  
 
10
 
8 
 
cells were stimulated with 8 
 
 
 
g/ml M4 for 3 min in 5 ml
RPMI 1640 at 37
 
 
 
C. Cells were washed with PBS containing 4
mM EDTA, and were lysed on ice in 1 ml 1% Triton X-100 in
MNE buffer (25 mM MES, pH 6.5, 150 mM NaCl, 5 mM
EDTA, and 1 mM sodium orthovanadate) supplemented with
protease and phosphatase inhibitors as described previously (10),
and were homogenized with 20 strokes in a tight-fitting dounce
homogenizer (Wheaton). The lysates were gently mixed with 1
ml of 80% (wt/vol) sucrose in MNE buffer and placed in the bot-
tom of a centrifuge tube. The samples were then overlaid on 6.5
ml of 30% sucrose and 2.5 ml of 5% sucrose in MNE buffer and
supercentrifuged for 20 h at 200,000 
 
g 
 
in a RPS40T rotor (Hita-
chi Instruments) at 4
 
 
 
C. Among 11 fractions collected from the
top of the gradient, fractions 3 and 4 corresponded to GEMs as
revealed by Western blot analysis using ganglioside GM1 and
anti-Lyn Ab. For immunoprecipitation, 10 mg/ml digitonin was
added to the fractions.
 
In Vitro Kinase Assay.
 
The in vitro kinase assay conditions for
ERK, p38, and JNK were described previously (29). In brief, ly-
sates from 2–5 
 
  
 
10
 
6 
 
cells were immunoprecipitated with 1 
 
 
 
g
anti-ERK2, anti-p38, or anti-JNK1 Abs with 40 
 
 
 
l protein
G–Sepharose. Half of the immune complexes were used for in
vitro kinase assay and the rest were used for Western blot analysis.
Immunoprecipitates were suspended in 30 
 
 
 
l kinase assay buffer
containing 10 
 
 
 
Ci [
 
 
 
-
 
32
 
P]ATP and 5 
 
 
 
M cold ATP. Glutathione
S–transferase (GST)-Elk, GST-ATF2, or GST–c-Jun fusion pro-
tein (5 
 
 
 
g each) was added as a substrate for ERK2, p38, or
JNK1, respectively. The reactions were performed at 30
 
 
 
C for 20
min. For in vitro kinase assay of Syk, Syk immunoprecipitates
were suspended in kinase assay buffer (20 mM Tris, pH 7.5, 10
mM MgCl
 
2
 
, and 10 mM MnCl
 
2
 
) in the presence of 10 
 
 
 
Ci [
 
 
 
-
 
32
 
P]ATP and 5 
 
 
 
M cold ATP. Recombinant GST fusion protein
containing a cytoplasmic region of mouse Ig
 
 
 
 (5 
 
 
 
g) was used as
an exogenous substrate (30). The reactions were performed at
30
 
 
 
C for 10 min. For in vitro kinase assay of Btk, Btk immuno-
precipitates were suspended in kinase assay buffer (20 mM Pipes,
pH 7.5, and 20 mM MnCl
 
2
 
) containing 10 
 
 
 
Ci [
 
 -32P]ATP, 5
 M cold ATP, and 5  g enolase (Sigma-Aldrich), and incubated
at 25 C for 3 min. The kinase reactions were terminated by the
addition of SDS sample buffer followed by boiling for 5 min. All
samples were separated by SDS-PAGE. The gels were dried and
subjected to autoradiography.
Ca2  Measurements.  DT40 and 2.5    106 cells were sus-
pended in HBSS supplemented with 10 mM Hepes, pH 7.2,
0.025% BSA, and 1 mM CaCl2, and loaded with 3  M acetoxy-
methyl ester of Fura-2 (Molecular Probes) at 30 C for 30 min.
Cytosolic Ca2  concentration of 5   105 cells in 0.5 ml HBSS
supplemented with 10 mM Hepes, pH 7.2, 0.025% BSA, and 1
mM CaCl2, was recorded at 510 nm emission wavelength excited
by 340 and 380 nm with a CAF110 spectrofluorometer
(JASCO). Ca2  release from intracellular Ca2  store was mea-
sured in 0.5 ml HBSS supplemented with 10 mM Hepes, pH 7.2,
0.025% BSA, and 1 mM EGTA. Mouse splenocytes were loaded
with 5  g/ml Indo-1 (Molecular Probes) at 30 C for 40 min,
and then labeled with FITC-conjugated anti-B220 Ab (BD
PharMingen). Ca2  mobilization of B220  cells was determined
by flow cytometry.
IP3 Generation Assay.  2   106 cells were stimulated with 2  g
M4 at 37 C for the indicated time. Analyses of IP3 production
were performed using the BIOTRAK IP3 assay system (Amersham
Pharmacia Biotech) according to the manufacturer’s protocol.
Binding Assay with GST Fusion Proteins. Human Btk cDNA
fragments encoding amino acids 276–401 (Btk SH2) and 219–
272 (Btk SH3), and rat PLC- 2 cDNA fragments encoding
amino acids 532–720 (PLC- 2 [SH2]2) and 769–831 (PLC- 2
SH3) were amplified by PCR. The PCR products were cloned
in frame into pGEX4T-1 vector (Amersham Pharmacia Biotech).
The constructs were verified by DNA sequencing. The pGEX-
RalGDS(Rap1 binding domain [RBD]) plasmid, which encodes
GST fusion protein containing the RBD of RalGDS, is as de-
scribed previously (31). GST fusion proteins were produced in
DH5 , and affinity purified by glutathione Sepharose beads (Am-
ersham Pharmacia Biotech). For in vitro binding assays, lysates
from Cbl-b–overexpressing WEHI-231 cells were incubated
with 3  g GST fusion proteins immobilized on glutathione
Sepharose for 4 h at 4 C. Bound proteins were washed and blot-
ted with anti–Cbl-b Ab. For Rap1 activation assay, cell lysates
were incubated with 50  g GST-RalGDS(RBD) immobilized
on glutathione Sepharose for 1 h at 4 C. Bound proteins were
washed and blotted with anti-Rap1 Ab.
Results
Requirement of Lyn and Syk in BCR-induced Tyrosine Phos-
phorylation of Cbl-b. Cbl-b becomes tyrosine phosphory-
lated upon stimulation of hematopoietic receptors such as
the TCR, FLT3 receptor, and IL-7R (32, 33). Because
Cbl-b is expressed in B cells, we tested whether Cbl-b, like
Cbl (34), is tyrosine phosphorylated upon stimulation of
BCR. As shown in Fig. 1 A, Cbl-b was rapidly tyrosine
phosphorylated, being maximally phosphorylated 3 min
after BCR stimulation in DT40 B cells. Tyrosine phos-
phorylation of Cbl-b was severely impaired in Lyn- and
Syk-deficient cells. In Btk-deficient DT40 cells, tyrosine
phosphorylation of Cbl-b was apparently suppressed at an
earlier time point (i.e., at 1 min), but not at a later time
point (i.e., at 10 min). This result is consistent with the
previous observation that Src family PTKs and Syk lead to
tyrosine phosphorylation of Cbl-b in COS-1 cells (32). After
BCR stimulation, the total amount of immunoprecipitated
Cbl-b was decreased in wild-type, Syk-, and Btk-deficient
cells, but not in Lyn-deficient cells. Lyn-mediated tyrosine
phosphorylation of Cbl-b may inhibit the binding of the
anti–Cbl-b Ab. Another possibility is that Cbl-b translo-
cates to the detergent insoluble fractions after BCR stimu-
lation in a Lyn-dependent manner.
Inhibition of BCR-induced PLC- 2 Activation in Cbl-b–
deficient DT40 B Cells.  To evaluate the function of Cbl-b
in B cells, we generated Cbl-b–deficient DT40 B cells by
the gene targeting method. Disruption of the chicken cbl-b
gene was accomplished by targeted mutation of an exon
corresponding to amino acids residues 242–281 of human
Cbl-b (Fig. 1, B and C). Lack of the cbl-b mRNA and Cbl-b
protein was verified by Northern and Western blot anal-54 Positive Role for Cbl-b in BCR Signaling
yses, respectively (Fig. 1, D and E). The level of cell surface
expression of BCR on the targeted DT40 cells was compa-
rable to that of parental cells (Fig. 1 F).
One of the crucial biochemical cascades in BCR signal-
ing is the PLC- 2/Ca2  pathway. As shown in Fig. 2 A,
BCR stimulation of DT40 cells deficient for Cbl-b showed
impaired Ca2  mobilization compared with wild-type cells.
To evaluate the effect of Cbl-b on calcium release from in-
ternal stores as well as extracellular calcium influx, cells in
medium containing EGTA were stimulated by anti-IgM
Ab, followed by the addition of molar excess of calcium.
The results showed that Ca2  release from internal stores
was impaired in Cbl-b–deficient cells. This was not due to
the lesser amount of Ca2  storage in the ER of Cbl-b–defi-
cient cells than in wild-type cells, because ionomycin-
induced calcium mobilization was not suppressed in the
absence of Cbl-b. Consistent with this observation, BCR-
induced IP3 production was remarkably impaired in Cbl-
b–deficient cells (Fig. 2 B). Because the activity of PLC- 2
is critically regulated by its tyrosine phosphorylation, we
evaluated the BCR-induced tyrosine phosphorylation sta-
tus of PLC- 2 in wild-type and Cbl-b–deficient cells. The
results showed that Cbl-b–deficient cells exhibited mark-
edly decreased levels of PLC- 2 tyrosine phosphorylation
(Fig. 2 C).
Suppression of Signaling Downstream of PLC- 2 in the
Absence of Cbl-b. As PLC- 2–mediated generation of di-
acylglycerol results in the activation of Rap1 (31), we ex-
amined whether Rap1 activation is impaired in Cbl-b–
deficient cells. BCR stimulation rapidly increased the
amount of activated Rap1 in wild-type cells. However,
Rap1 activation was suppressed or delayed in Cbl-b–defi-
cient cells (Fig. 2 D), which suggests that PLC- 2 activa-
tion was impaired in the absence of Cbl-b. PLC- 2 is also
implicated in the BCR-induced activation of MAPKs,
ERK, JNK, and p38 (29). As shown in Fig. 2, E and F,
the levels of BCR-induced activation of ERK2 and p38
were only slightly less in Cbl-b–deficient cells than in
wild-type cells. In contrast, BCR-induced JNK activation
was dramatically reduced by the loss of Cbl-b (Fig. 2 G).
Because PLC- 2 and JNK are relevant to apoptosis (35–
37), we examined the possible involvement of Cbl-b in
the BCR-induced apoptosis of DT40 cells. The popula-
tion of apoptotic cells in the absence of Cbl-b was  20%
less than that in the presence of Cbl-b, as measured by the
level of endonucleolytically cleaved DNA (unpublished
data). Thus, BCR-induced apoptosis was also suppressed,
in part, in Cbl-b–deficient cells. Taken together, we con-
clude that BCR-induced tyrosine phosphorylation and
the activation of PLC- 2 are suppressed in the absence of
Cbl-b.
Effect of Cbl-b on the BCR-induced Activation of Syk and
Btk.  It is possible that the BCR-induced activation of
Syk and Btk is down-regulated in Cbl-b–deficient cells,
which results in the attenuation of PLC- 2 phosphoryla-
tion. To examine this possibility, the overall BCR-induced
tyrosine phosphorylation pattern was first compared be-
tween wild-type and Cbl-b–deficient cells. As shown in
Figure 1. Tyrosine phosphorylation of Cbl-b and generation of Cbl-b–
deficient DT40 B cells. (A) At the indicated time points after stimulation
of 8  g/ml M4, wild-type, Lyn-, Syk-, or Btk-deficient DT40 cells
(2.5   107) were lysed in 1% NP-40 lysis buffer containing 10 mg/ml
digitonin. Anti–Cbl-b (C-20) immunoprecipitates from the lysates were
subjected to Western blot analysis with anti-phosphotyrosine mAb (top)
and anti–Cbl-b (C-20) Ab (bottom). (B) Structure of the chicken cbl-b al-
lele, the targeting vector, and the mutated allele. Restriction sites for
EcoRI (E) are indicated. (C) Southern blot analysis of wild-type and tar-
geted DT40 cells. EcoRI-digested genomic DNAs were separated on an
agarose gel, blotted, and hybridized with the chicken cbl-b cDNA probe
(B, 5  probe). (D) Northern blot analysis of wild-type and Cbl-b–defi-
cient DT40 cells using chicken cDNA probe for cbl-b (top) or  -actin
(bottom). (E) Protein expression of Cbl-b in wild-type and Cbl-b–defi-
cient DT40 cells. Immunoprecipitates with anti–Cbl-b (C-20) Ab were
prepared from wild-type and Cbl-b–deficient DT40 cells and subjected to
Western blot analysis using anti–Cbl-b (C-20) Ab. (F) BCR expression
on the surface of wild-type (wt), Cbl-b–deficient (cbl-b , C3-1, and C3-3),
and various DT40 derivatives were monitored by flow cytometry. Un-
stained cells were used as the negative controls (dashed histogram). Wild-
type and Cbl-b–deficient cells expressing T7-tagged Btk are indicated
as T7-Btk/wt and T7-Btk/cbl-b , respectively. Cbl-b–deficient cells (C3-3)
expressing wild-type Cbl-b, G298E mutant Cbl-b, COOH-terminal de-
letion mutant Cbl-b (1-444 amino acids), and C373A mutant Cbl-b are
shown as WT/cbl-b , GE/cbl-b , N/cbl-b , and CA/cbl-b , respectively.
The x and y axes for the histograms indicate fluorescence intensity (four-
decade log scales) and relative cell number, respectively.55 Yasuda et al.
Fig. 3 A, the kinetics and extent of BCR-induced tyrosine
phosphorylation of cellular proteins were nearly compara-
ble, or the extent was marginally enhanced, in Cbl-b–defi-
cient cells. BCR-induced activation of Syk and Btk was
then examined in vitro. Because the Ab raised against
chicken Btk does not immunoprecipitate Btk efficiently,
we stably expressed a T7 epitope–tagged Btk (designated
T7-Btk) in wild-type and Cbl-b–deficient cells. Clones ex-
pressing similar levels of T7-Btk and surface IgM were se-
lected (Fig. 1 F). The activities and kinetics of Syk and Btk
were nearly the same between the wild-type and Cbl-b–
deficient cells (Fig. 3, B and C). Moreover, Syk and Btk
were inducibly tyrosine phosphorylated to an almost similar
extent in wild-type and Cbl-b–deficient cells (Fig. 3, B
and D). Consistently, BCR-induced phosphorylation of
BLNK, a prominent substrate of Syk (38), was almost com-
parable between wild-type and mutant cells (Fig. 3 E).
Therefore, we concluded that the loss of Cbl-b had no no-
table effects on either Syk or Btk tyrosine kinase activities
in stimulated B cells.
Role of Cbl-b on the Association of Btk, BLNK, and PLC-
 2 in BCR Signaling.  BCR-induced activation of the
Ca2  pathway requires Syk-dependent assembly of signal-
ing components such as Btk, BLNK, and PLC- 2 (39).
Because Cbl-b contains various protein–protein interaction
domains, it may serve as a scaffolding protein in BCR sig-
naling. To evaluate this possibility, tyrosine-phosphorylated
proteins coimmunoprecipitated with Syk or Btk were
compared between wild-type and Cbl-b–deficient cells.
We found no significant differences in the pattern of tyro-
sine-phosphorylated proteins coimmunoprecipitated with
Syk between wild-type and Cbl-b–deficient cells (Fig. 3
B). In contrast, a tyrosine-phosphorylated protein, pp80,
was coimmunoprecipitated with Btk in a Cbl-b–dependent
manner after BCR stimulation (Fig. 3 D). Because the Btk
SH2 domain interacts with phosphorylated BLNK in a
Figure 2. Characterization of the PLC- 2/
Ca2  signaling, Rap1 activation, and MAPKs
activation in Cbl-b–deficient DT40 cells. (A)
Ca2  mobilization in wild-type DT40 cells (red)
and Cbl-b–deficient cells, and clones C3-1
(blue) and C3-3 (green). [Ca2 ]i were moni-
tored by spectrophotometer after stimulation
with 2  g/ml M4 or 0.5  g/ml ionomycin.
Ca2  release from intracellular Ca2  store was
monitored after stimulation with 2  g/ml M4
in the presence of 1 mM EGTA ( EGTA).
Ca2  was restored to the media to evaluate ex-
tracellular Ca2  influx. Arrows indicate the time
point of the addition of M4 (     ), ionomy-
cin, and CaCl2. Similar results were obtained
using two other Cbl-b–deficient clones. (B) IP3
production in wild-type and Cbl-b–deficient
DT40 cells. 2   106 cells were stimulated with
2  g M4 for the indicated time period and IP3
production was measured. Results are the
mean   SEM of three independent experiments.
(C) Tyrosine phosphorylation of PLC- 2 in
wild-type and Cbl-b–deficient DT40 cells. 107
cells were lysed in 1% NP-40 lysis buffer at the
indicated time points after stimulation of 4  g/ml
M4. Anti–PLC- 2 immunoprecipitates from
the lysates were subjected to Western blot anal-
ysis with anti-phosphotyrosine mAb (top) and
anti–PLC- 2 Ab (bottom). (D) Rap1 activation
in wild-type and Cbl-b–deficient DT40 cells.
1.25   107 cells were lysed in 1% NP-40 lysis
buffer at the indicated time points after stimula-
tion of 5  g/ml M4. Cell lysates were precipi-
tated with GST-RalGDS(RBD) immobilized
on glutathione Sepharose, and bound proteins
were analyzed by anti-Rap1 immunoblotting.
(E–G) BCR-induced ERK2, p38, and JNK
activation in wild-type and Cbl-b–deficient
DT40 cells. 2.5   107 cells were lysed at the in-
dicated time points after stimulation of 4  g/ml
M4. (E) Anti-ERK2, (F) anti-p38, or (G) anti-
JNK1 immunoprecipitates from the lysates
were subjected to kinase reaction using GST-Elk, GST-ATF2, or GST–c-Jun as an exogenous substrate, respectively. The protein levels in the immuno-
precipitates are shown in E–G. All experiments were performed more than three times.56 Positive Role for Cbl-b in BCR Signaling
BCR-dependent manner, and chicken BLNK is estimated
to be 80 kD (25, 40), we assumed that the 80-kD protein
might be BLNK. Indeed, BCR-induced association of Btk
with BLNK was inhibited by the loss of Cbl-b (Fig. 4 A),
despite comparable levels of BLNK phosphorylation in the
wild-type and Cbl-b–deficient cells (Fig. 3 E). Phosphory-
lated BLNK binds to PLC- 2 and then the resultant
BLNK–PLC- 2 complex translocates to the membrane,
which leads to PLC- 2 activation (25, 41). The recruit-
ment of PLC- 2 to Btk was also impaired in Cbl-b–defi-
cient cells (Fig. 4 A). Thus, Cbl-b positively regulates the
recruitment of both BLNK and PLC- 2 to close proximity
of Btk in activated B cells.
BCR-dependent Interaction of Cbl-b with Btk, BLNK, and
PLC- 2, and Their Translocation to GEMs.  We then ad-
dressed whether Cbl-b forms a signaling complex with
Btk, BLNK, and PLC- 2. As shown in Fig. 4, A–C, Cbl-b
associated with Btk, BLNK, and PLC- 2 in the BCR-
stimulated cells expressing T7-tagged Btk. The immuno-
depletion of Btk resulted in a 30–50% decrease in the
amount of Cbl-b in the anti–Cbl-b immunoprecipitates.
Furthermore, the interaction between Cbl-b and PLC- 2
was completely abrogated by Btk immunoprecipitation
(Fig. 4 D). These results indicate that BCR-induced Btk–
Cbl-b complex also includes PLC- 2 as a component.
Recent evidence shows that the activation of immune re-
ceptors, such as BCR, TCR, and FcR, is followed by the
accumulation of tyrosine-phosphorylated receptors and
the associated signaling molecules in the GEMs (42–45).
The disruption of GEMs results in the attenuation of anti-
gen receptor–mediated calcium mobilization. Therefore,
we examined whether Cbl-b and its associated proteins are
recruited to GEMs after BCR stimulation. Fractionation
of the cell lysates in sucrose density gradients showed that
Lyn was enriched in Triton-insoluble GEMs (fractions 3
and 4) and  -tubulin in Triton-soluble fractions (fractions
9–11; Fig. 4 E, top). A small fraction of Cbl-b was present
in the GEMs of unstimulated cells. Interestingly, the pro-
Figure 3. BCR-induced activation of Syk and Btk.
(A) Tyrosine phosphorylation profiles of wild-type and
Cbl-b–deficient (C3-3) DT40 cells. Whole cell lysates
were prepared at the indicated time points after stimu-
lation of 4  g/ml M4. The lysates were subjected to
Western blot analysis with anti-phosphotyrosine mAb.
(B) Tyrosine phosphorylation and kinase activity of
Syk. Wild-type or Cbl-b–deficient (C3-3) DT40 cells
were lysed at the indicated time points after stimulation
of 4  g/ml M4. Anti-Syk immunoprecipitates from
the lysates were equally divided, and aliquots (one third
of the lysates) were subjected to in vitro kinase assay
with GST-Ig  as a substrate (top), and the remaining
immunoprecipitates were analyzed by Western blot
analysis with anti-phosphotyrosine mAb (middle) and
anti-Syk Ab (bottom). (C) Kinase activity of Btk.
Wild-type or Cbl-b–deficient DT40 cells expressing
T7-tagged Btk were lysed at the indicated time points
after stimulation of 4  g/ml M4. Anti-T7 immunopre-
cipitates from the lysates were equally divided, and half
of them were subjected to in vitro kinase assay with
enolase as a substrate (top), and the remaining half were
analyzed by Western blot analysis with anti-T7 mAb
(bottom). (D) Tyrosine phosphorylation of Btk. Wild-
type or Cbl-b–deficient DT40 cells expressing T7-
tagged Btk were lysed in 0.2% NP-40 lysis buffer at the
indicated time points after stimulation of 4  g/ml M4.
Anti-T7 immunoprecipitates from the lysates were
used for Western blot analysis with anti-phosphoty-
rosine mAb (top) and anti-T7 mAb (bottom). (E) Ty-
rosine phosphorylation of BLNK. Wild-type or Cbl-b–
deficient (C3-3) DT40 cells (5   106) were lysed in 1%
NP-40 lysis buffer at the indicated time points after
stimulation of 4  g/ml M4. Anti-BLNK immunopre-
cipitates from the lysates were subjected to Western
blot analysis with anti-phosphotyrosine mAb (top) and
anti-BLNK Ab (bottom). All experiments were per-
formed more than three times.57 Yasuda et al.
portion of Cbl-b in GEMs greatly increased after BCR
stimulation (Fig. 4 E, bottom left). Small but significant
amounts of PLC- 2, BLNK, and Btk in GEMs were also
increased after BCR stimulation in the presence but not
the absence of Cbl-b (Fig. 4 E, bottom right). Impor-
tantly, these proteins in GEMs were coimmunoprecipi-
tated with Cbl-b. These data suggest that Cbl-b trans-
locates to GEMs in a manner dependent on BCR
stimulation. Cbl-b in GEMs likely serves as a scaffold pro-
tein for Btk, BLNK, and PLC- 2, resulting in the activa-
tion of PLC- 2.
We have previously shown that Cbl directly binds to
phosphorylated BLNK via its TKB domain. This binding
inhibits interaction between BLNK and PLC- 2, and sub-
sequent PLC- 2 activation (18). Despite the high homol-
ogy between Cbl and Cbl-b (82% identity in the amino
acid sequences at the TKB domains), the BLNK–PLC- 2
interaction was not affected by the loss of Cbl-b (Fig. 4 F).
Both the protein level and tyrosine phosphorylation status
of Cbl were not affected by the absence of Cbl-b (Fig. 4
G). These data suggest that Cbl and Cbl-b have distinct
roles in the regulation of PLC- 2.
Figure 4. BCR-induced association of Cbl-b, Btk,
BLNK, and PLC- 2 and their translocation into
GEMs. (A) Interaction of BLNK, PLC- 2, or Cbl-b
with Btk. Wild-type or Cbl-b–deficient DT40 cells
expressing T7-tagged Btk were lysed in 0.2% NP-40
lysis buffer at the indicated time points after stimulation
of 4  g/ml M4. Anti-T7 immunoprecipitates from the
lysates were subjected to Western blot analysis with
anti–PLC- 2 Ab, anti–Cbl-b (C-20) Ab, anti-BLNK
Ab, and anti-T7 mAb. (B) BCR-induced interaction
between Cbl-b and PLC- 2. Wild-type or Cbl-b–
deficient (C3-3) DT40 cells were lysed in 1% NP-40
lysis buffer at the indicated time points after stimulation
of 4  g/ml M4. Anti–Cbl-b (C-20) immunoprecipi-
tates from the lysates were subjected to Western blot
analysis with anti–PLC- 2 Ab (top) and anti–Cbl-b
(C-20) Ab (bottom). (C) BCR-induced interaction be-
tween Cbl-b and BLNK. Wild-type or Cbl-b–deficient
(C3-3) DT40 cells were lysed in 1% NP-40 lysis buffer
at the indicated time points after stimulation of 4  g/
ml M4. Anti–Cbl-b (C-20) immunoprecipitates from
the lysates were subjected to Western blot analysis with
anti-BLNK Ab (top) and anti–Cbl-b (C-20) Ab (bot-
tom). (D) Wild-type DT40 cells expressing T7-tagged
Btk were stimulated with 8  g/ml M4 for 3 min. Cell
lysates with or without immunodepletion of Btk using
anti-T7 mAb were immunoprecipitated with anti–
Cbl-b (C-20) Ab (lanes 1 and 2) or anti-T7 mAb (lane
3). Immunoprecipitates or whole cell lysates were sub-
jected to Western blot analysis with anti–PLC- 2 Ab,
anti–Cbl-b (C-20) Ab, and anti-T7 mAb. (E) Wild-
type or Cbl-b–deficient DT40 cells expressing T7-
tagged Btk, unstimulated ( ) or stimulated ( ) with
8  g/ml M4 for 3 min, were lysed and fractionated by
the sucrose gradient (top). Fractions (30  l/lane; num-
bered from 5 to 40% density) were resolved by SDS-
PAGE and subjected to Western blot analysis with
anti– -tubulin mAb or anti-Lyn Ab (bottom left).
Anti–Cbl-b immunoprecipitates from fractions 3 and 4
(GEMs), or fraction 11 (Triton soluble) of the sucrose
gradient, were subjected to Western blot analysis with
anti–Cbl-b Ab (C-20), anti-BLNK Ab, anti–PLC- 2
Ab, and anti-T7 mAb (bottom right). Whole cell ly-
sates, anti-T7 immunoprecipitates, and anti-BLNK
immunoprecipitates from fractions 3, 4, and 11 of the
sucrose gradient were subjected to Western blot analy-
sis with anti–PLC- 2 Ab, anti-T7 mAb, anti-BLNK
Ab, and anti–Cbl-b Ab (C-20). (F) Wild-type, Cbl-b–
(C3-3), or Cbl-deficient DT40 cells were lysed in 1%
NP-40 lysis buffer at the indicated time points after
stimulation of 4  g/ml M4. Anti–PLC- 2 immuno-
precipitates from the lysates were used for Western blot analysis with anti-BLNK Ab (top) and anti–PLC- 2 Ab (bottom). (G) Tyrosine phosphorylation
of Cbl in wild-type and Cbl-b–deficient DT40 cells. 107 cells were lysed in 1% NP-40 lysis buffer at the indicated time points after stimulation of 4  g/ml
M4. Anti-Cbl immunoprecipitates from the lysates were subjected to Western blot analysis with anti-phosphotyrosine mAb (top) and anti-Cbl Ab
(bottom). All experiments were performed more than three times.58 Positive Role for Cbl-b in BCR Signaling
Regulation of Btk-dependent Sustained Ca2  Flux by
Cbl-b.  To further confirm that Cbl-b positively regulates
Btk-mediated PLC- 2 activation, we examined the role of
Cbl-b in Btk-dependent intracellular Ca2  ([Ca2 ]i) in-
crease upon BCR stimulation. Consistent with the findings
of Takata and Kurosaki (11) and Fluckiger et al. (46), the
overexpression of Btk in wild-type DT40 cells resulted in
an enhanced and sustained increase in [Ca2 ]i after BCR
stimulation. In contrast, the overexpression of Btk in Cbl-
b–deficient cells induced an initial but not sustained in-
crease in [Ca2 ]i. Within 4 min after BCR stimulation,
[Ca2 ]i of these cells decreased to a level comparable with
that in parental Cbl-b–deficient cells (Fig. 5 A). The pro-
duction of IP3 and the tyrosine phosphorylation of PLC- 2
were enhanced and sustained in wild-type DT40 cells
overexpressing Btk, but those in Cbl-b–deficient cells
overexpressing Btk were transient (Fig. 5, B and C). Thus,
we concluded that Cbl-b is a positive regulator of Btk-
dependent activation of PLC- 2/Ca2  signaling.
Requirement of the TKB Domain and COOH-terminal Re-
gion of Cbl-b for Cbl-b-dependent [Ca2 ]i Elevation. To de-
termine the region(s) within Cbl-b that is responsible for
the regulation of PLC- 2/Ca2  signaling, we generated
stable clones expressing the wild-type or mutant Cbl-b
protein in Cbl-b–deficient cells (Fig. 6 A). Clones express-
ing similar amounts of Cbl-b and surface IgM were selected
(Fig. 1 F and Fig. 6 B). The level of BCR-induced tyrosine
phosphorylation of Cbl-b was not affected much by the
mutations in the TKB or RING finger domain, but com-
pletely abolished by COOH-terminal deletion (Fig. 6 B).
Upon BCR stimulation, Cbl-b–deficient cells expressing
wild-type Cbl-b (WT/cbl-b ) showed enhanced and sus-
tained Ca2  mobilization in comparison to that of parental
Cbl-b–deficient cells, confirming the positive role of Cbl-b
in PLC- 2/Ca2  signaling (Fig. 6 C). The expression of a
TKB mutant (Gly298 to Glu in the SH2 domain, GE), or a
COOH-terminal deletion mutant (1–444 amino acids, N),
did not restore the defect of Cbl-b–deficient cells in BCR-
induced Ca2  mobilization (Fig. 6 C). The Ca2  mobiliza-
tion was also not restored in Cbl-b–deficient cells expressing
a RING finger mutant (Cys373 to Ala, CA). Intriguingly,
however, a low level of sustained Ca2  mobilization was
observed in the CA mutant–expressing cells. It should be
noted that the introduction of wild-type or CA mutant
Cbl-b into Cbl-b–deficient cells resulted in an excessive in-
crease of extracellular Ca2  influx (Fig. 6 C, bottom),
which might be related to the sustained Ca2  mobilization
seen in these cells. The mechanism underlying the in-
creased influx remains to be addressed. In contrast to wild-
type Cbl-b, none of these Cbl-b mutants interacted with
PLC- 2 upon BCR stimulation (Fig. 6 D). These results
show that the TKB domain, the COOH-terminal region,
and the RING finger domain of Cbl-b are important for
Btk-mediated PLC- 2 activation. In vitro GST pull-down
experiments revealed that the SH3 but not the SH2 do-
mains of Btk and PLC- 2 interacted with Cbl-b from the
B cells with or without BCR stimulation (Fig. 6 E). These
data suggest that Btk and PLC- 2 could interact with Cbl-b
via its SH3 domains in direct or indirect mechanisms. The
mode of interaction through the TKB domain likely re-
quires the modification or structural alteration of Cbl-b
(see Discussion).
Effect of Cbl-b on BCR-mediated Calcium Signaling in
Mouse B Cells.  To examine whether or not Cbl-b
positively regulates PLC- /Ca2  signaling, we generated
WEHI-231 mouse B cell lines overexpressing Cbl-b,
Figure 5.  Role of Cbl-b on Btk-dependent Ca2 
mobilization, IP3 production, and tyrosine phosphory-
lation of PLC- 2. Wild-type cells, Cbl-b–deficient
cells, wild-type cells expressing T7-tagged Btk (C38-9
and C38-11), and Cbl-b–deficient cells expressing T7-
tagged Btk (C37-4 and C37-10) were analyzed for (A)
BCR-induced Ca2  mobilization, (B) IP3 production,
and (C) tyrosine phosphorylation of PLC- 2, as de-
scribed in Fig. 2. Similar results were obtained using
two other Cbl-b–deficient clones. All experiments
were performed more than three times.59 Yasuda et al.
termed C85-11 and C85-12 (Fig. 7 A). As shown in Fig.
7, B and C, BCR stimulation of these cells resulted in
enhanced PLC- 2 phosphorylation and Ca2  mobiliza-
tion. Therefore, Cbl-b regulates PLC- 2/Ca2  signaling
positively in mouse B cells as well. Unexpectedly, how-
ever, the extent of calcium flux (Fig. 7 D) and tyrosine
phosphorylation of PLC- 2 (Fig. 7 E) in BCR-stimu-
lated splenic B cells from Cbl-b–deficient mice was simi-
lar to that in wild-type mice. These data suggest the pres-
ence of compensatory mechanisms for the PLC- /Ca2 
signaling pathway in mouse splenic B cells (see Discus-
sion).
Discussion
Cbl family proteins Cbl and Cbl-b have been implicated
in signal transduction of lymphocyte antigen receptors (13).
In this study, we show that both Lyn and Syk are required
for tyrosine phosphorylation of Cbl-b after BCR stimula-
tion. Because Syk, but not Lyn, is dispensable for BCR-
induced tyrosine phosphorylation of Cbl (34), tyrosine
phosphorylation of Cbl and Cbl-b induced by BCR stimu-
lation is likely to be regulated by distinct mechanisms. We
show that Cbl-b positively regulates BCR-induced PLC-
 2/Ca2  signaling, and provide evidence suggesting that
Cbl-b functions as a scaffold protein to promote Btk-medi-
ated PLC- 2 activation.
Figure 6. Effects of mutations in Cbl-b on BCR-
induced Ca2  mobilization. (A) Schematic representa-
tion of the wild-type and mutant Cbl-b proteins. 4H,
four-helix bundle; EF, EF hand; SH2, Src homology 2;
RF, RING finger; PRO, proline-rich region; LZ, leu-
cine zipper. (B) Expression and tyrosine phosphoryla-
tion of wild-type or mutant Cbl-b in Cbl-b–deficient
cells. The indicated cells were lysed in 1% NP-40 lysis
buffer at 0, 1, and 3 min after stimulation of 4  g/ml
M4. Anti–Cbl-b (G-1) immunoprecipitates from the
lysates were subjected to Western blot analysis with
anti-phosphotyrosine mAb (top) and anti–Cbl-b (G-1)
mAb (bottom). The positions of WT, GE, N, and CA
Cbl-b are indicated. (C) BCR-induced Ca2  mobiliza-
tion in wild-type cells, Cbl-b–deficient cells (C3-3),
and Cbl-b–deficient cells expressing wild-type Cbl-b
(WT/cbl-b ), G298E Cbl-b (GE/cbl-b ), a COOH-
terminal deletion mutant (N/cbl-b ), or C373A Cbl-b
(CA/cbl-b ). [Ca2 ]i were monitored by spectropho-
tometer after stimulation with 2  g/ml M4 ( EGTA).
Ca2  release from intracellular Ca2  store was moni-
tored after stimulation of 2  g/ml M4 in the presence
of 1 mM EGTA ( EGTA), and Ca2  was restored to
the media to evaluate extracellular Ca2  influx. Arrows
indicate the time point of the addition of M4 (     )
and CaCl2. The representative results from four inde-
pendent clones of each cell type are shown. (D) Associ-
ation of Cbl-b with PLC- 2. The indicated cells were
lysed in 1% NP-40 lysis buffer at 0, 1, and 3 min after
stimulation of 4  g/ml M4. Anti–PLC- 2 immuno-
precipitates from the lysates were subjected to Western
blot analysis with anti–Cbl-b (G-1) mAb (top) and
anti–PLC- 2 Ab (bottom). The positions of WT, GE,
N, and CA Cbl-b are indicated. (E) In vitro binding of
Cbl-b with the SH3 domains of Btk and PLC- 2.
WEHI-231 cells overexpressing Cbl-b (C85-11) and
unstimulated ( ) or stimulated ( ) with anti-IgM (10
 g/107 cells) for 3 min, were lysed in 1% NP-40 lysis
buffer, and the lysates were incubated with the indi-
cated GST fusion proteins immobilized on glutathione
Sepharose. The bound proteins or lysates (1/10 input)
were separated by SDS-PAGE and immunoblotted
with anti–Cbl-b (G-1) mAb (left). Expression of the
GST fusion proteins was confirmed by Coomassie
staining (right). (C–E) Experiments were performed
more than three times.60 Positive Role for Cbl-b in BCR Signaling
Syk and Btk are required for tyrosine phosphorylation
and activation of PLC- 2. A previous report shows that the
Syk-related protein Zap-70 is positively regulated by Cbl-b
in Jurkat T cells (47). Therefore, it is possible that Syk ac-
tivity is suppressed in the absence of Cbl-b. However, this
is unlikely because in vitro kinase activities and tyrosine
phosphorylation of Syk were nearly the same between
wild-type and Cbl-b–deficient cells. Consistently, recent
findings show no significant differences in the TCR-
induced tyrosine phosphorylation of Zap-70 and Lck in T
cells from Cbl-b–deficient mice (17, 23). We also show
that Btk activity is not affected in the absence of Cbl-b.
BCR-induced activation of the PLC- 2/Ca2  pathway
requires the assembly of signaling components Btk, BLNK,
and PLC- 2. A crucial adaptor protein, BLNK, couples
Syk and Btk to PLC- 2 activation in B cells (39). A possi-
ble explanation for the attenuated phosphorylation of PLC-
 2 in Cbl-b–deficient cells is that Cbl-b acts as a scaffolding
protein to promote a complex formation including PLC-
 2. In accordance with this idea, our present data strongly
argues that Cbl-b contributes to complex formation among
Btk, BLNK, and PLC- 2, which leads to the activation of
PLC- 2. GEMs have been proposed to function as plat-
forms for the formation of multicomponent signaling com-
plexes (48). Our data in Fig. 4 suggest that BCR stimula-
tion induces the translocation of Cbl-b, Btk, BLNK, and
PLC- 2 to GEMs where Cbl-b interacts with these pro-
teins. Because the translocation of PLC-  to GEMs is es-
sential for its tyrosine phosphorylation and subsequent acti-
vation in antigen receptor signaling (43, 44), Cbl-b–
dependent translocation of Btk, BLNK, and PLC- 2 into
GEMs suggests the importance of Cbl-b in the regulation
of PLC- 2/Ca2  signaling (Fig. 4). Overexpression of Btk
in B cells significantly enhanced the sustained increase in
[Ca2 ]i after BCR activation (Fig. 5; references 11 and 46).
In Cbl-b–deficient B cells, however, Btk overexpression
only induced a transient increase of [Ca2 ]i in the early
phase after BCR stimulation (Fig. 5). Obviously, Cbl-b is
important for the sustained activation of PLC- 2 through
Btk that is likely to occur in GEMs.
Here we show that Cbl-b–dependent positive regulation
of Ca2   mobilization requires its TKB domain and
COOH-terminal half, and that these domains are essential
for its interaction with PLC- 2. Although Cbl suppresses
BCR-induced PLC- 2 activation by inhibiting BLNK–
PLC- 2 interaction (18), Cbl-b does not inhibit this inter-
action. These differential effects on the binding of PLC- 2
to BLNK could be due to the sequence divergence at the
COOH-terminal region between Cbl and Cbl-b, and
would account for the functional difference between the
two proteins. In vitro binding analysis revealed that the
SH3 domain, but not the SH2 domain, of both Btk and
PLC- 2 interacts with Cbl-b in the absence of BCR stim-
ulation. However, the interaction of Cbl-b with Btk,
Figure 7. Role of Cbl-b on the PLC- 2/Ca2  path-
way in mouse B cells. (A) Whole cell lysate (5   105
cells) from parental and Cbl-b–overexpressing (C85-11
and C85-12) WEHI-231 mouse B cells were analyzed
by Western blot analysis using anti–Cbl-b (G-1) mAb.
(B) Parental and Cbl-b–overexpressing (C85-11)
WEHI-231 cells (3   106) were stimulated with anti-
IgM (10  g/107 cells) for 3 min. Anti–PLC- 2 immu-
noprecipitates from the lysates were subjected to West-
ern blot analysis with anti-phosphotyrosine mAb (top)
and anti–PLC- 2 mAb (bottom). (C) BCR-induced
Ca2  mobilization in parental and Cbl-b–overexpress-
ing (C85-11 and C85-12) WEHI-231 cells. [Ca2 ]i
were monitored by spectrophotometer after stimula-
tion with 2  g/ml anti-IgM. Arrows indicate the time
point of the addition of anti-IgM (     ). (D) BCR-
induced Ca2  mobilization in B cells from wild-type
(Cbl-b / ) and Cbl-b–deficient (Cbl-b / ) mice.
Splenocytes were loaded with Indo-1, labeled with
B220-FITC, and stimulated with anti-IgM (10  g/107
cells). Data are presented as the median ratio of Ca2 
bound to Ca2 -free Indo-1 fluorescence of B220  cells
as measured by flow cytometry. (E) 3   106 splenic B
cells of wild-type (Cbl-b / ) or Cbl-b–deficient
(Cbl-b / ) mice were stimulated with anti-IgM for 1
min. Anti–PLC- 2 immunoprecipitates from the ly-
sates were subjected to Western blot analysis with anti-
phosphotyrosine mAb (top) and anti–PLC- 2 mAb
(bottom). All experiments were performed more than
three times.61 Yasuda et al.
BLNK, and PLC- 2 occurred in a manner dependent on
BCR stimulation, which suggests that tyrosine phosphory-
lation events are required for the interaction in vivo. Be-
cause the NH2-terminal 418–amino acid sequence of Cbl-b,
including the TKB domain, did not bind to either Btk,
BLNK, or PLC- 2 in vitro (unpublished data), the binding
of Cbl-b TKB domain to target proteins may require its
structural modification, such as tyrosine phosphorylation
and the help of the COOH-terminal sequence of Cbl-b.
Unlike in DT40 B cells, the extent of tyrosine phos-
phorylation of PLC- 2 and calcium flux in BCR-stimu-
lated splenic B cells from Cbl-b–deficient mice was similar
to that from wild-type mice (Fig. 7). This is unlikely to be
due to the difference in the mechanisms underlying PLC-
 2/Ca2  signaling between mouse and chicken, because
the overexpression of Cbl-b enhanced tyrosine phosphory-
lation of PLC- 2 as well as Ca2  mobilization in WEHI-
231 mouse B cells. Intriguingly, TCR-induced tyrosine
phosphorylation of PLC- 1 is unaffected in the absence of
Cbl-b (17, 23). In contrast, TCR-induced tyrosine phos-
phorylation of PLC- 1 is reduced in Cbl-deficient T cells
(22). These data suggest that both Cbl and Cbl-b could
positively regulate PLC- /Ca2  signaling and Cbl compen-
sates antigen receptor–mediated activation of PLC-  in
lymphocytes of Cbl-b–deficient mice. Indeed, TCR-stim-
ulated tyrosine phosphorylation of PLC- 1 and Ca2  mo-
bilization were severely impaired in mouse T cells lacking
both Cbl and Cbl-b (unpublished data). It should also be
noted that Cbl-b–deficient lymphocytes are hyperprolifera-
tive in the mouse system despite that PLC- /Ca2  signal-
ing is unaffected in these lymphocytes (Fig. 7; references 17
and 23). Moreover, mouse T cells lacking both Cbl and
Cbl-b were hyperproliferative upon TCR stimulation,
even in the impairment of PLC- 1/Ca2  signaling (unpub-
lished data). Taken together, we assume that PLC- /Ca2 
signaling is regulated by Cbl family proteins and that it may
not necessarily be linked to the proliferative activity of
lymphocytes in vivo. It appears that mouse B cells deficient
for Cbl-b are hyperproliferative upon BCR stimulation
due to yet unknown mechanisms downstream of Cbl-b de-
ficiency. The PI3K pathway may be negatively regulated
by Cbl-b in B cells, like in T cells (24), which would, at
least in part, explain the hyperproliferation of Cbl-b–defi-
cient splenic B cells. In addition, consistent with the en-
hanced phosphorylation of Vav1 and Vav2 in TCR-stimu-
lated Cbl-b–deficient thymocytes (23, 49), we observed
enhanced tyrosine phosphorylation of Vav2 in BCR-stim-
ulated Cbl-b–deficient DT40 B cells (unpublished data).
Because Vav1 and Vav2 are indispensable for BCR-stimu-
lated B cell proliferation (50), the hyperproliferative nature
of Cbl-b–deficient B cells may due to the hyperactivation
of Vav. It is also possible that the internalization of acti-
vated surface BCR is suppressed in the absence of Cbl-b.
This would extend the duration of BCR signaling, which
results in enhanced B cell proliferation.
Cbl has the RING-type ubiquitin protein ligase activity
and promotes the ubiquitination of activated receptor
PTKs such as EGFR (20). Cbl-b promotes the ubiquitina-
tion of EGFR and the p85 regulatory subunit of PI3K (20,
24). However, the protein levels of Syk, Btk, BLNK, and
PLC- 2 are not affected in Cbl- (18) or Cbl-b–deficient
(Figs. 2 and 3) DT40 B cells. In addition, in both Cbl- and
Cbl-b–deficient T cells, the protein levels of Zap-70, Lck,
Slp-76, LAT, PLC- 1, and Vav1 are also not affected be-
fore or after TCR stimulation (17, 21–23). These data sug-
gest that Cbl family–dependent ubiquitination and subse-
quent proteolysis of these signaling proteins are less likely
to be involved in antigen receptor–mediated signaling. Be-
cause a RING finger mutant of Cbl-b (Cys373 to Ala) did
not bind to PLC- 2 upon BCR stimulation, the RING
finger domain of Cbl family proteins may be used to regu-
late protein–protein interaction that are relevant to Ca2 
flux (Fig. 6).
Cbl negatively regulates various tyrosine kinase signaling
pathways such as EGFR (20), Zap-70 (51), and Syk (52).
Cbl, on the other hand, positively regulates IL-4 receptor
signaling (53),  1 integrin signaling in macrophage (54),
c-Src–mediated signaling in bone resorption (55), and TNF
receptor superfamily signaling (56). Our present findings
show that Cbl-b can positively regulate BCR-induced
PLC- 2/Ca2  signaling. Similarly, TCR-induced PLC- /
Ca2  signaling appears to be positively regulated by Cbl-b
as well as by Cbl, as is evidenced by the analysis of T cell
signaling in mice lacking Cbl and/or Cbl-b (17, 22, 23, and
unpublished data). It should be noted that Cbl is involved
in ITAM-based signaling and forms a signaling complex
containing SLP-76 upon Fc RI stimulation of myeloid
cells (19). Likewise, Cbl-b may be involved in the ITAM
signaling downstream of Fc R, Fc R, as well as BCR.
Thus, Cbl family proteins play diverse roles depending
upon the signaling pathways in which they are involved.
The balance between the levels of Cbl and Cbl-b, as well as
the dynamics of their compartmentalization in signaling
complexes, would be important for the surface receptor–
mediated activation of hematopoietic cells.
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